REPORT ID 5375

Global Novel Drug Delivery Systems (NDDS) Market Research Report 2017

Publish Date
21-Dec-17
Pages
119
Format
Electronic (PDF)

In this report, the global Novel Drug Delivery Systems (NDDS) market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Novel Drug Delivery Systems (NDDS) in these regions, from 2012 to 2022 (forecast), covering
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
Global Novel Drug Delivery Systems (NDDS) market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
    3M
    GSK
    AstraZeneca
    Cipla
    Chiesi
    Boehringer Ingelheim
    Aptar
    Novartis
    Philips Respironics
    Omron Healthcare
    PARI
    Skyepharma
    CareFusion
    Shanghai Huarui
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Embolization Particles
    Liquid Embolics
    Nanoparticles
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
    Cancer Therapy
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Global Novel Drug Delivery Systems (NDDS) Market Research Report 2017
1 Novel Drug Delivery Systems (NDDS) Market Overview
    1.1 Product Overview and Scope of Novel Drug Delivery Systems (NDDS)
    1.2 Novel Drug Delivery Systems (NDDS) Segment by Type (Product Category)
        1.2.1 Global Novel Drug Delivery Systems (NDDS) Production and CAGR (%) Comparison by Type (Product Category)(2012-2022)
        1.2.2 Global Novel Drug Delivery Systems (NDDS) Production Market Share by Type (Product Category) in 2016
        1.2.3 Embolization Particles
        1.2.4 Liquid Embolics
        1.2.5 Nanoparticles
    1.3 Global Novel Drug Delivery Systems (NDDS) Segment by Application
        1.3.1 Novel Drug Delivery Systems (NDDS) Consumption (Sales) Comparison by Application (2012-2022)
        1.3.2 Cancer Therapy
        1.3.3 Others
    1.4 Global Novel Drug Delivery Systems (NDDS) Market by Region (2012-2022)
        1.4.1 Global Novel Drug Delivery Systems (NDDS) Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
        1.4.2 North America Status and Prospect (2012-2022)
        1.4.3 Europe Status and Prospect (2012-2022)
        1.4.4 China Status and Prospect (2012-2022)
        1.4.5 Japan Status and Prospect (2012-2022)
        1.4.6 Southeast Asia Status and Prospect (2012-2022)
        1.4.7 India Status and Prospect (2012-2022)
    1.5 Global Market Size (Value) of Novel Drug Delivery Systems (NDDS) (2012-2022)
        1.5.1 Global Novel Drug Delivery Systems (NDDS) Revenue Status and Outlook (2012-2022)
        1.5.2 Global Novel Drug Delivery Systems (NDDS) Capacity, Production Status and Outlook (2012-2022)

2 Global Novel Drug Delivery Systems (NDDS) Market Competition by Manufacturers
    2.1 Global Novel Drug Delivery Systems (NDDS) Capacity, Production and Share by Manufacturers (2012-2017)
        2.1.1 Global Novel Drug Delivery Systems (NDDS) Capacity and Share by Manufacturers (2012-2017)
        2.1.2 Global Novel Drug Delivery Systems (NDDS) Production and Share by Manufacturers (2012-2017)
    2.2 Global Novel Drug Delivery Systems (NDDS) Revenue and Share by Manufacturers (2012-2017)
    2.3 Global Novel Drug Delivery Systems (NDDS) Average Price by Manufacturers (2012-2017)
    2.4 Manufacturers Novel Drug Delivery Systems (NDDS) Manufacturing Base Distribution, Sales Area and Product Type
    2.5 Novel Drug Delivery Systems (NDDS) Market Competitive Situation and Trends
        2.5.1 Novel Drug Delivery Systems (NDDS) Market Concentration Rate
        2.5.2 Novel Drug Delivery Systems (NDDS) Market Share of Top 3 and Top 5 Manufacturers
        2.5.3 Mergers & Acquisitions, Expansion

3 Global Novel Drug Delivery Systems (NDDS) Capacity, Production, Revenue (Value) by Region (2012-2017)
    3.1 Global Novel Drug Delivery Systems (NDDS) Capacity and Market Share by Region (2012-2017)
    3.2 Global Novel Drug Delivery Systems (NDDS) Production and Market Share by Region (2012-2017)
    3.3 Global Novel Drug Delivery Systems (NDDS) Revenue (Value) and Market Share by Region (2012-2017)
    3.4 Global Novel Drug Delivery Systems (NDDS) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.5 North America Novel Drug Delivery Systems (NDDS) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.6 Europe Novel Drug Delivery Systems (NDDS) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.7 China Novel Drug Delivery Systems (NDDS) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.8 Japan Novel Drug Delivery Systems (NDDS) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.9 Southeast Asia Novel Drug Delivery Systems (NDDS) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.10 India Novel Drug Delivery Systems (NDDS) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 Global Novel Drug Delivery Systems (NDDS) Supply (Production), Consumption, Export, Import by Region (2012-2017)
    4.1 Global Novel Drug Delivery Systems (NDDS) Consumption by Region (2012-2017)
    4.2 North America Novel Drug Delivery Systems (NDDS) Production, Consumption, Export, Import (2012-2017)
    4.3 Europe Novel Drug Delivery Systems (NDDS) Production, Consumption, Export, Import (2012-2017)
    4.4 China Novel Drug Delivery Systems (NDDS) Production, Consumption, Export, Import (2012-2017)
    4.5 Japan Novel Drug Delivery Systems (NDDS) Production, Consumption, Export, Import (2012-2017)
    4.6 Southeast Asia Novel Drug Delivery Systems (NDDS) Production, Consumption, Export, Import (2012-2017)
    4.7 India Novel Drug Delivery Systems (NDDS) Production, Consumption, Export, Import (2012-2017)

5 Global Novel Drug Delivery Systems (NDDS) Production, Revenue (Value), Price Trend by Type
    5.1 Global Novel Drug Delivery Systems (NDDS) Production and Market Share by Type (2012-2017)
    5.2 Global Novel Drug Delivery Systems (NDDS) Revenue and Market Share by Type (2012-2017)
    5.3 Global Novel Drug Delivery Systems (NDDS) Price by Type (2012-2017)
    5.4 Global Novel Drug Delivery Systems (NDDS) Production Growth by Type (2012-2017)

6 Global Novel Drug Delivery Systems (NDDS) Market Analysis by Application
    6.1 Global Novel Drug Delivery Systems (NDDS) Consumption and Market Share by Application (2012-2017)
    6.2 Global Novel Drug Delivery Systems (NDDS) Consumption Growth Rate by Application (2012-2017)
    6.3 Market Drivers and Opportunities
        6.3.1 Potential Applications
        6.3.2 Emerging Markets/Countries

7 Global Novel Drug Delivery Systems (NDDS) Manufacturers Profiles/Analysis
    7.1 3M
        7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.1.2 Novel Drug Delivery Systems (NDDS) Product Category, Application and Specification
            7.1.2.1 Product A
            7.1.2.2 Product B
        7.1.3 3M Novel Drug Delivery Systems (NDDS) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.1.4 Main Business/Business Overview
    7.2 GSK
        7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.2.2 Novel Drug Delivery Systems (NDDS) Product Category, Application and Specification
            7.2.2.1 Product A
            7.2.2.2 Product B
        7.2.3 GSK Novel Drug Delivery Systems (NDDS) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.2.4 Main Business/Business Overview
    7.3 AstraZeneca
        7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.3.2 Novel Drug Delivery Systems (NDDS) Product Category, Application and Specification
            7.3.2.1 Product A
            7.3.2.2 Product B
        7.3.3 AstraZeneca Novel Drug Delivery Systems (NDDS) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.3.4 Main Business/Business Overview
    7.4 Cipla
        7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.4.2 Novel Drug Delivery Systems (NDDS) Product Category, Application and Specification
            7.4.2.1 Product A
            7.4.2.2 Product B
        7.4.3 Cipla Novel Drug Delivery Systems (NDDS) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.4.4 Main Business/Business Overview
    7.5 Chiesi
        7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.5.2 Novel Drug Delivery Systems (NDDS) Product Category, Application and Specification
            7.5.2.1 Product A
            7.5.2.2 Product B
        7.5.3 Chiesi Novel Drug Delivery Systems (NDDS) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.5.4 Main Business/Business Overview
    7.6 Boehringer Ingelheim
        7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.6.2 Novel Drug Delivery Systems (NDDS) Product Category, Application and Specification
            7.6.2.1 Product A
            7.6.2.2 Product B
        7.6.3 Boehringer Ingelheim Novel Drug Delivery Systems (NDDS) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.6.4 Main Business/Business Overview
    7.7 Aptar
        7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.7.2 Novel Drug Delivery Systems (NDDS) Product Category, Application and Specification
            7.7.2.1 Product A
            7.7.2.2 Product B
        7.7.3 Aptar Novel Drug Delivery Systems (NDDS) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.7.4 Main Business/Business Overview
    7.8 Novartis
        7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.8.2 Novel Drug Delivery Systems (NDDS) Product Category, Application and Specification
            7.8.2.1 Product A
            7.8.2.2 Product B
        7.8.3 Novartis Novel Drug Delivery Systems (NDDS) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.8.4 Main Business/Business Overview
    7.9 Philips Respironics
        7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.9.2 Novel Drug Delivery Systems (NDDS) Product Category, Application and Specification
            7.9.2.1 Product A
            7.9.2.2 Product B
        7.9.3 Philips Respironics Novel Drug Delivery Systems (NDDS) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.9.4 Main Business/Business Overview
    7.10 Omron Healthcare
        7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.10.2 Novel Drug Delivery Systems (NDDS) Product Category, Application and Specification
            7.10.2.1 Product A
            7.10.2.2 Product B
        7.10.3 Omron Healthcare Novel Drug Delivery Systems (NDDS) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.10.4 Main Business/Business Overview
    7.11 PARI
    7.12 Skyepharma
    7.13 CareFusion
    7.14 Shanghai Huarui

8 Novel Drug Delivery Systems (NDDS) Manufacturing Cost Analysis
    8.1 Novel Drug Delivery Systems (NDDS) Key Raw Materials Analysis
       8.1.1 Key Raw Materials
       8.1.2 Price Trend of Key Raw Materials
       8.1.3 Key Suppliers of Raw Materials
       8.1.4 Market Concentration Rate of Raw Materials
    8.2 Proportion of Manufacturing Cost Structure
       8.2.1 Raw Materials
       8.2.2 Labor Cost
       8.2.3 Manufacturing Expenses
    8.3 Manufacturing Process Analysis of Novel Drug Delivery Systems (NDDS)

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
    9.1 Novel Drug Delivery Systems (NDDS) Industrial Chain Analysis
    9.2 Upstream Raw Materials Sourcing
    9.3 Raw Materials Sources of Novel Drug Delivery Systems (NDDS) Major Manufacturers in 2015
    9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
    10.1 Marketing Channel
        10.1.1 Direct Marketing
        10.1.2 Indirect Marketing
        10.1.3 Marketing Channel Development Trend
    10.2 Market Positioning
        10.2.1 Pricing Strategy
        10.2.2 Brand Strategy
        10.2.3 Target Client
    10.3 Distributors/Traders List

11 Market Effect Factors Analysis
    11.1 Technology Progress/Risk
        11.1.1 Substitutes Threat
        11.1.2 Technology Progress in Related Industry
    11.2 Consumer Needs/Customer Preference Change
    11.3 Economic/Political Environmental Change

12 Global Novel Drug Delivery Systems (NDDS) Market Forecast (2017-2022)
    12.1 Global Novel Drug Delivery Systems (NDDS) Capacity, Production, Revenue Forecast (2017-2022)
        12.1.1 Global Novel Drug Delivery Systems (NDDS) Capacity, Production and Growth Rate Forecast (2017-2022)
        12.1.2 Global Novel Drug Delivery Systems (NDDS) Revenue and Growth Rate Forecast (2017-2022)
        12.1.3 Global Novel Drug Delivery Systems (NDDS) Price and Trend Forecast (2017-2022)
    12.2 Global Novel Drug Delivery Systems (NDDS) Production, Consumption , Import and Export Forecast by Region (2017-2022)
        12.2.1 North America Novel Drug Delivery Systems (NDDS) Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.2 Europe Novel Drug Delivery Systems (NDDS) Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.3 China Novel Drug Delivery Systems (NDDS) Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.4 Japan Novel Drug Delivery Systems (NDDS) Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.5 Southeast Asia Novel Drug Delivery Systems (NDDS) Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.6 India Novel Drug Delivery Systems (NDDS) Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
    12.3 Global Novel Drug Delivery Systems (NDDS) Production, Revenue and Price Forecast by Type (2017-2022)
    12.4 Global Novel Drug Delivery Systems (NDDS) Consumption Forecast by Application (2017-2022)

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology/Research Approach
        14.1.1 Research Programs/Design
        14.1.2 Market Size Estimation
        14.1.3 Market Breakdown and Data Triangulation
    14.2 Data Source
        14.2.1 Secondary Sources
        14.2.2 Primary Sources
    14.3 Disclaimer